These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Pimecrolimus 1% cream (Elidel) for atopic dermatitis.
    Author: Bernard LA, Bergman JN, Eichenfield LF.
    Journal: Skin Therapy Lett; 2002 Apr; 7(4):1-3. PubMed ID: 12097994.
    Abstract:
    Pimecrolimus is an immunomodulating medication that inhibits production of inflammatory cytokines in the skin and this compound was specifically developed for the treatment of inflammatory skin diseases. Phase II and III clinical trials with the topical formulation of pimecrolimus (Elidel cream, Novartis) have shown that it is safe and effective for use in patients with atopic dermatitis (AD). The US FDA recently approved Elidel for use in patients >or=2 years of age and older with mild to moderate atopic dermatitis (AD).
    [Abstract] [Full Text] [Related] [New Search]